Ibrahim, Ashraf S.

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

Spellberg, B., Edwards, J., & Ibrahim, A. (2005) · Clinical Microbiology Reviews

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,537

Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells

Phan, Q. T., Myers, C. L., Fu, Y., Sheppard, D. C., Yeaman, M. R., Welch, W. H., Ibrahim, A. S., Edwards, J. E., & Filler, S. G. (2007) · PLoS Biology

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 641

COVID-19-associated fungal infections

Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 482

The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

Spellberg, B., Ibrahim, A. S., Chin-Hong, P. V., Kontoyiannis, D. P., Morris, M. I., Perfect, J. R., Fredricks, D., & Brass, E. P. (2012) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 308

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 308

Functional and Structural Diversity in the Als Protein Family of Candida albicans

Sheppard, D. C., Yeaman, M. R., Welch, W. H., Phan, Q. T., Fu, Y., Ibrahim, A. S., Filler, S. G., Zhang, M., Waring, A. J., & Edwards, J. E. (2004) · Journal of Biological Chemistry

Fungal and yeast genetics researchAntifungal resistance and susceptibility

Cited by 300

Cloning and Disruption of caPLB1, a Phospholipase B Gene Involved in the Pathogenicity of Candida albicans

Leidich, S. D., Ibrahim, A. S., Fu, Y., Koul, A., Jessup, C., Vitullo, J., Fonzi, W., Mirbod, F., Nakashima, S., Nozawa, Y., et al. (1998) · Journal of Biological Chemistry

Fungal and yeast genetics researchAntifungal resistance and susceptibility

Cited by 241

Mice with Disseminated Candidiasis Die of Progressive Sepsis

Spellberg, B., Ibrahim, A. S., Edwards Jr., J. E., & Filler, S. G. (2005) · The Journal of Infectious Diseases

Antifungal resistance and susceptibilitySepsis Diagnosis and Treatment

Cited by 230

Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections

Shaw, K. J., & Ibrahim, A. S. (2020) · Journal of Fungi

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 229

Mechanism of Fluconazole Resistance in Candida krusei

Orozco, A. S., Higginbotham, L. M., Hitchcock, C. A., Parkinson, T., Falconer, D., Ibrahim, A. S., Ghannoum, M. A., & Filler, S. G. (1998) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 218

Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway

Fu, Y., Ibrahim, A. S., Sheppard, D. C., Chen, Y., French, S. W., Cutler, J. E., Filler, S. G., & Edwards, J. E. (2002) · Molecular Microbiology

Fungal and yeast genetics researchAntifungal resistance and susceptibility

Cited by 218

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

Edwards, J. E., Schwartz, M. M., Schmidt, C. S., Sobel, J. D., Nyirjesy, P., Schodel, F., Marchus, E., Lizakowski, M., DeMontigny, E. A., Hoeg, J., et al. (2018) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 213

Efficacy of the Anti‐Candida rAls3p‐N or rAls1p‐N Vaccines against Disseminated and Mucosal Candidiasis

Spellberg, B. J., Ibrahim, A. S., Avanesian, V., Fu, Y., Myers, C., Phan, Q. T., Filler, S. G., Yeaman, M. R., & Edwards, Jr. (2006) · The Journal of Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 180

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection

Singh, S., Uppuluri, P., Mamouei, Z., Alqarihi, A., Elhassan, H., French, S., Lockhart, S. R., Chiller, T., Edwards, J. E., & Ibrahim, A. S. (2019) · PLOS Pathogens

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 162

A Candida auris –specific adhesin, Scf1 , governs surface association, colonization, and virulence

Santana, D. J., Anku, J. A. E., Zhao, G., Zarnowski, R., Johnson, C. J., Hautau, H., Visser, N. D., Ibrahim, A. S., Andes, D., Nett, J. E., et al. (2023) · Science

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 142

Candida albicans Hyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target

Luo, G., Ibrahim, A. S., Spellberg, B., Nobile, C. J., Mitchell, A. P., & Fu, Y. (2010) · The Journal of Infectious Diseases

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 125

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis

Alkhazraji, S., Gebremariam, T., Alqarihi, A., Gu, Y., Mamouei, Z., Singh, S., Wiederhold, N. P., Shaw, K. J., & Ibrahim, A. S. (2020) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 97

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity

Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 83

Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule

Ibrahim, A. S., Filler, S. G., Alcouloumre, M. S., Kozel, T. R., Edwards, J. E., & Ghannoum, M. A. (1995) · Infection and Immunity

Fungal Infections and StudiesBacterial Infections and Vaccines

Cited by 83

Functional analysis of the Candida albicans ALS1 gene product

Loza, L., Fu, Y., Ibrahim, A. S., Sheppard, D. C., Filler, S. G., & Edwards, J. E. (2004) · Yeast

Fungal and yeast genetics researchAntifungal resistance and susceptibility

Cited by 78

Small-Molecule Inhibitors of the Budded-to-Hyphal-Form Transition in the Pathogenic Yeast Candida albicans

Toenjes, K. A., Munsee, S. M., Ibrahim, A. S., Jeffrey, R., Edwards, J. E., & Johnson, D. I. (2005) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 72

The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis

Ibrahim, A. S., Gebremariam, T., French, S. W., Edwards, J. E., & Spellberg, B. (2010) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 68

Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.

Luo, G., Ibrahim, A. S., French, S. W., Edwards, J. E., & Fu, Y. (2011) · PLoS ONE

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 62

Fob1 and Fob2 proteins are virulence determinants of Rhizopus oryzae via facilitating iron uptake from Ferrioxamine

Liu, M., Lin, L., Gebremariam, T., Luo, G., Skory, C. D., French, S. W., Chou, T.-F., Edwards, J. E., & Ibrahim, A. S. (2015) · PLOS Pathogens

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 62